Omicron Now Has Three Sub-Variants, Say Experts

HYDERABAD : The variant of concern, Omicron, has now three siblings – one up from two sub-lineages discovered last week.

According to Phylogenetic Assignment of Named Global Outbreak Lineages (PANGOLIN) that assigns lineages under ‘Pango lineage’ system to various viruses including the novel coronavirus that causes Covid-19, the third outlier of Omicron was found from a sample collected from England on December 3. The new outlier of Omicron variant is temporarily named England/MILK-2D24AC9/2021.

Dr Vinod Scaria of Institute of Genomics and Integrative Biology (IGIB), New Delhi, confirmed the development by tweeting late on Sunday about the new outlier of Omicron lineage with some shared mutations.

Omicron variant or B.1.1.529 split into two sub-lineages BA.1 and BA.2 earlier this month. These two variants have some shared mutations, besides some mutations that are unique to them. “A new diverse genome has appeared within the B.1.1.529 lineage that has all of the shared mutations of B.1.1.529, some of the mutations unique to BA.1 and some unique to BA.2 plus a few of its own,” PANGOLIN announced in its website.

It added it seems likely the new Omicron outlier is an additional circulating member of B.1.1.529 diversity and recombination has occurred in its history. It also said it “may have mutated prior to emergence of BA.1 clade based on pattern of mutations.” It said, “as a single genome it doesn’t yet require a lineage designation and at the moment it will be classified as a member of Omicron”. Experts say though Omicron has been spreading faster than previous variants, most cases are mild.

  • Related Posts

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad